Page URL:

Alzheimer's gene variant impairs the middle-aged, scientists say

19 July 2010
Appeared in BioNews 567

Middle-aged people without Alzheimer's disease who have a 'high risk' variant of the TOMM40 gene are more likely to have poorer memory, new research findings suggest.

The study looked at 726 middle-aged people with a family history of Alzheimer's disease, genotyped them for the TOMM40 and APOE gene variants and then conducted a range of cognitive tests.

The TOMM40 and APOE gene variants have already been linked to Alzheimer's disease in previous studies. Researchers at Duke University in North Carolina led by Professor Allen Roses discovered the TOMM40 gene and its association with Alzheimer's disease, which is also close to APOE in the genome.

The researchers found that those individuals with a 'high risk' variant of the TOMM40 gene (129 people) performed significantly worse than individuals with a 'low risk' variant (229 people) in a series of memory tests.

Professor Clive Ballard from the Alzheimer's Society in the UK said 'These interesting preliminary studies have shown a gene linked to Alzheimer's also alters cognitive function in mid-life'.

'A better understanding of how genetic and other risk factors lead to cognitive impairment in mid-life will help researchers target prevention of dementia more effectively'.

The findings were announced at the Alzheimer's Association International Conference on Alzheimer's (AAICAD) in Hawaii on the 14 July by researchers at the University of Wisconsin Medical School. 

Alzheimer’s Gene Acts on Middle-Aged People, Researchers Say
Businessweek |  14 July 2010
Alzheimer's gene linked to cognitive impairment in mid-life
Alzheimer's Society |  14 July 2010
18 August 2014 - by Chris Hardy 
A man without a working copy of a gene thought to be necessary for healthy brain function - and linked with Alzheimer's disease - has a 'grossly normal cognitive status'. Targeting this gene in people at-risk for the disease could help to protect them against it...
18 February 2013 - by Michelle Downes 
Hormone replacement therapy, used to treat the symptoms of menopause, may play a role in slowing the ageing process in women who carry a certain gene variant, claim scientists...
11 April 2011 - by Alison Cranage 
International scientists including researchers at Cardiff University, UK and the University of Pennsylvania, USA have discovered five genetic variations associated with Alzheimer's disease. The findings are published in two papers in the journal Nature Genetics...
7 March 2011 - by Alison Cranage 
Scientists at Northwestern University, Chicago have transformed stem cells into a key type of brain cell that dies early in Alzheimer's disease. Their findings will allow scientists to study what causes the cells to die in Alzheimer's, potentially paving the way for new treatments....
27 September 2010 - by Alison Cranage 
US scientists have identified a gene which they suggest is associated with Alzheimer's and could help uncover the causes of the disease....
26 April 2010 - by Dr Charlotte Maden 
The obesity-related gene FTO also plays a role in loss of brain tissue, according to a US study published in the Proceedings of the National Academy of Sciences last week...
22 February 2010 - by Ruth Pidsley 
An international team of scientists have identified two genetic variants associated with fronto-temporal dementia (FTD), a common form of early onset dementia. The study, published in Nature Genetics, could help in the search for new treatments to tackle the disease....
15 February 2010 - by Ruth Pidsley 
Scientists have identified a genetic variant that may influence the rate at which a person will age. The finding, published in last week's edition of the journal Nature Genetics, could help identify which individuals are most susceptible to common age-related conditions, such as heart disease and Alzheimer's disease....
7 September 2009 - by Ailsa Stevens 
British and French researchers this week announced the discovery of three new genes linked to late-onset Alzheimer's disease, certain variations in which may increase a person's risk of developing the disease by 10-15 per cent. If new drugs could be developed to counter the effects of these mutations, it could help to prevent 20 per cent, the equivalent of 100,000 cases, of Alzheimer's disease in the UK per year, the researchers claim....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.